ATE501280T1 - Verfahren zum nachweis eines analyten in einer biologischen matrix - Google Patents

Verfahren zum nachweis eines analyten in einer biologischen matrix

Info

Publication number
ATE501280T1
ATE501280T1 AT07727792T AT07727792T ATE501280T1 AT E501280 T1 ATE501280 T1 AT E501280T1 AT 07727792 T AT07727792 T AT 07727792T AT 07727792 T AT07727792 T AT 07727792T AT E501280 T1 ATE501280 T1 AT E501280T1
Authority
AT
Austria
Prior art keywords
analyte
detecting
biological matrix
sample
dilution buffer
Prior art date
Application number
AT07727792T
Other languages
English (en)
Inventor
Michael Adler
Original Assignee
Chimera Biotec Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38462758&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE501280(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Chimera Biotec Gmbh filed Critical Chimera Biotec Gmbh
Application granted granted Critical
Publication of ATE501280T1 publication Critical patent/ATE501280T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54393—Improving reaction conditions or stability, e.g. by coating or irradiation of surface, by reduction of non-specific binding, by promotion of specific binding
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6804—Nucleic acid analysis using immunogens
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54306—Solid-phase reaction mechanisms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AT07727792T 2007-04-04 2007-04-04 Verfahren zum nachweis eines analyten in einer biologischen matrix ATE501280T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP2007/053323 WO2008122310A1 (en) 2007-04-04 2007-04-04 Method for the detection of an analyte in biological matrix

Publications (1)

Publication Number Publication Date
ATE501280T1 true ATE501280T1 (de) 2011-03-15

Family

ID=38462758

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07727792T ATE501280T1 (de) 2007-04-04 2007-04-04 Verfahren zum nachweis eines analyten in einer biologischen matrix

Country Status (6)

Country Link
US (1) US20100291562A1 (de)
EP (1) EP2132339B1 (de)
AT (1) ATE501280T1 (de)
DE (1) DE602007013110D1 (de)
DK (1) DK2132339T3 (de)
WO (1) WO2008122310A1 (de)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102008047790A1 (de) * 2008-09-17 2010-04-15 Qiagen Gmbh Verfahren zur Normierung des Gehalts von Biomolekülen in einer Probe
CN105388293A (zh) 2008-12-31 2016-03-09 雅培医护站股份有限公司 用于使用核苷酸缀合物的免疫测定的方法和设备
US9714937B2 (en) * 2009-10-13 2017-07-25 Nanostring Technologies, Inc. Protein detection via nanoreporters
GB201011971D0 (en) 2010-07-15 2010-09-01 Olink Ab Methods and product
JP5852334B2 (ja) * 2011-06-07 2016-02-03 株式会社日立ハイテクノロジーズ 自動分析方法
DE102014010333A1 (de) 2014-07-14 2016-01-14 Qiagen Gmbh Verfahren zum Nachweis wenigstens eines Zielanalyten in einer Probe
CN107208136A (zh) * 2014-12-18 2017-09-26 通用电气医疗集团英国有限公司 通过与免疫测定法偶联的核酸扩增的固体支持物上的分析物检测
CA2995204A1 (en) 2015-08-10 2017-02-16 Essenlix Corp. Bio/chemical assay devices and methods for simplified steps, small samples, accelerated speed, and ease-of-use
KR20190057445A (ko) 2015-09-14 2019-05-28 에센릭스 코프. 샘플 특히 혈액샘플을 분석하기 위한 장치와 시스템 및 그 사용 방법
US10132794B2 (en) 2015-09-14 2018-11-20 Essenlix Corporation Device and system for collecting and analyzing vapor condensate, particularly exhaled breath condensate, as well as method of using the same
US10628693B2 (en) 2016-12-21 2020-04-21 Essenlix Corporation Devices and methods for authenticating a sample and use of the same
JP7003158B2 (ja) 2017-02-07 2022-01-20 エッセンリックス コーポレーション 圧縮開放流アッセイおよび使用
CA3052809A1 (en) 2017-02-08 2018-08-23 Essenlix Corporation Qmax assays and applications
CA3053002A1 (en) 2017-02-08 2018-08-16 Essenlix Corp. Bio/chemical material extraction and assay
US12569851B2 (en) 2017-02-08 2026-03-10 Essenlix Corporation Digital assay
WO2018148470A1 (en) 2017-02-08 2018-08-16 Essenlix Corporation Sample collection and handling for delayed analysis
CN122234927A (zh) 2017-02-08 2026-06-19 上海宜晟生物科技有限公司 通过控制温度的分子操作和检测
JP2020507770A (ja) 2017-02-09 2020-03-12 エッセンリックス コーポレーション 比色アッセイ法
CA3053114A1 (en) 2017-02-09 2018-08-16 Essenlix Corporation Assay using different spacing heights
CA3053132A1 (en) 2017-02-09 2018-08-16 Essenlix Corp. Assay with amplification
CA3053295A1 (en) 2017-02-15 2018-08-23 Essenlix Corporation Assay with rapid temperature change
CN111448449B (zh) 2017-02-16 2024-08-27 上海宜晟生物科技有限公司 采用纹理化表面的测定方法及装置
US12181472B2 (en) 2017-06-12 2024-12-31 Essenlix Corporation Homogeneous assay
US11280706B2 (en) 2017-08-01 2022-03-22 Essenlix Corporation Dilution calibration
US11725227B2 (en) 2017-08-01 2023-08-15 Essenlix Corporation Devices and methods for examining drug effects on microorganisms
CN111492222A (zh) 2017-08-01 2020-08-04 Essenlix公司 样品收集、保持和测定
WO2019075244A1 (en) 2017-10-11 2019-04-18 Essenlix Corporation CONTAINING A LIQUID SAMPLE
WO2019075415A1 (en) 2017-10-13 2019-04-18 Essenlix Corporation DEVICES AND METHODS FOR AUTHENTICATING MEDICAL ANALYSIS AND USES THEREOF
US10807095B2 (en) 2017-10-26 2020-10-20 Essenlix Corporation Making and tracking assay card
US11237113B2 (en) 2017-10-26 2022-02-01 Essenlix Corporation Rapid pH measurement
US11609224B2 (en) 2017-10-26 2023-03-21 Essenlix Corporation Devices and methods for white blood cell analyses
WO2019118652A1 (en) 2017-12-12 2019-06-20 Essenlix Corporation Sample manipulation and assay with rapid temperature change
CN112534259A (zh) 2017-12-14 2021-03-19 Essenlix公司 监测毛发的装置，系统和方法
WO2019140334A1 (en) 2018-01-11 2019-07-18 Essenlix Corporation Homogeneous assay (ii)
US11885952B2 (en) 2018-07-30 2024-01-30 Essenlix Corporation Optics, device, and system for assaying and imaging

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4376110A (en) * 1980-08-04 1983-03-08 Hybritech, Incorporated Immunometric assays using monoclonal antibodies
US4816567A (en) * 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US4946778A (en) * 1987-09-21 1990-08-07 Genex Corporation Single polypeptide chain binding molecules
ATE318832T1 (de) * 1990-06-11 2006-03-15 Gilead Sciences Inc Verfahren zur vervendung von nukleinsäureliganden
US5496938A (en) * 1990-06-11 1996-03-05 Nexstar Pharmaceuticals, Inc. Nucleic acid ligands to HIV-RT and HIV-1 rev
US5270163A (en) * 1990-06-11 1993-12-14 University Research Corporation Methods for identifying nucleic acid ligands
DE69129154T2 (de) * 1990-12-03 1998-08-20 Genentech, Inc., South San Francisco, Calif. Verfahren zur anreicherung von proteinvarianten mit geänderten bindungseigenschaften
WO1992015708A1 (en) * 1991-02-27 1992-09-17 Amoco Corporation Methods for improving the sensitivity of hybridization assays
PT100379B (pt) * 1991-04-10 1999-01-29 Scripps Research Inst Bibliotecas de receptores heterodimericos usando fagomideos
US5733743A (en) * 1992-03-24 1998-03-31 Cambridge Antibody Technology Limited Methods for producing members of specific binding pairs
WO1994006920A1 (en) * 1992-09-22 1994-03-31 Medical Research Council Recombinant viruses displaying a nonviral polypeptide on their external surface
JPH08178926A (ja) * 1994-10-25 1996-07-12 Sumitomo Pharmaceut Co Ltd イムノアッセイプレートおよびその用途
US5496398A (en) * 1994-10-28 1996-03-05 Thiele Kaolin Company Reduction of microorganisms in kaolin clay slurries
US5702892A (en) * 1995-05-09 1997-12-30 The United States Of America As Represented By The Department Of Health And Human Services Phage-display of immunoglobulin heavy chain libraries
US6665317B1 (en) * 1999-10-29 2003-12-16 Array Telecom Corporation Method, system, and computer program product for managing jitter
US20050079520A1 (en) * 2003-07-21 2005-04-14 Jie Wu Multiplexed analyte detection

Also Published As

Publication number Publication date
DK2132339T3 (da) 2011-06-27
EP2132339B1 (de) 2011-03-09
WO2008122310A1 (en) 2008-10-16
EP2132339A1 (de) 2009-12-16
US20100291562A1 (en) 2010-11-18
DE602007013110D1 (de) 2011-04-21

Similar Documents

Publication Publication Date Title
DE602007013110D1 (de) Verfahren zum nachweis eines analyten in einer biologischen matrix
EP2883037C0 (de) Verfahren und vorrichtung zur durchführung und quantifizierung von farbveränderungen durch spezifische konzentrationen von biologischen analyten in einer automatisch kalibrierten umgebung
ATE538386T1 (de) Nachweis von krebs anhand von erhöhten bcl-2- konzentrationen
ATE479780T1 (de) Qpcr unter verwendung eines ionen-sensitiven feldeffekt-transistors zur ph-messung
ATE522627T1 (de) Verfahren zur herstellung von nukleinsäuresonden
EP1849001A4 (de) Seitenstrom-testsatz und verfahren zum nachweis eines analyten
BRPI0814202A2 (pt) Métodos e sistemas de determinação de concentração de produto de análise em amostra fluida e meio legível em computador
ZA201403386B (en) A method of detecting and/or quantifying an analyte in a biological sample
MY170164A (en) Aptamer-based multiplexed assays
GB2458855A (en) Detection device and methods of use
WO2013157917A3 (en) A biosensor and preparation method thereof
EP2449129A4 (de) Verfahren zur bestimmung des vorhandenseins und/oder der konzentration eines analyts in einer probe
EP2772761A3 (de) Nukleinsäureelement zur Verwendung für Analysen sowie Analyseverfahren, Analysereagens und Analyseinstrument damit
DE602009001116D1 (de) Verfahren zur Erkennung eines oralen Plattenepithelkarzinoms und Mittel zu dessen Unterdrückung
ATE541216T1 (de) Fluoreszenztestverfahren
DE602006011917D1 (de) Verfahren und substanzen zur isolierung von mirnas
WO2015059487A3 (en) Detection of cleavage activity of an enzyme
IN2014KN01352A (de)
WO2011137388A3 (en) Identification and use of biomarkers for detection and quantification of the level of radiation exposure in a biological sample
ATE519107T1 (de) Verfahren zur tacrolimus-extraktion und - quantifizierung unter verwendung wässriger detergentien
ATE529533T1 (de) Verfahren zum nachweis von analyten in einer probe
EP2281186A4 (de) Vorrichtung und verfahren zur optischen messung einer analytkonzentration in einer erythrozytenhaltigen flüssigkeit
WO2013121368A3 (en) A process for detection and optional quantification of an analyte
ATE503846T1 (de) Verfahren zur diagnose eines ovarialkarzinoms
ATE550655T1 (de) Verfahren zur bestimmung eines analyten in einer körperflüssigkeit

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties